A bibliometric and visualized research on global trends of immune checkpoint inhibitors related complications in melanoma, 2011–2021
BackgroundMelanoma is a malignant tumor that originates from the canceration of melanocytes with a high rate of invasiveness and lethality. Immune escape has been regarded as an important mechanism for tumor development, while the treatment of immune checkpoint inhibitors (ICIs) is beneficial in res...
Main Authors: | Hongyi Zhang, Yanlong Shi, Jianghui Ying, Yi Chen, Rong Guo, Xin Zhao, Lingling Jia, Jiachao Xiong, Fei Jiang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-04-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2023.1164692/full |
Similar Items
-
Update on Immune Checkpoint Inhibitors for Conjunctival Melanoma
by: Ho-Seok Sa, et al.
Published: (2022-08-01) -
Long-Term Toxicities of Immune Checkpoint Inhibitor (ICI) in Melanoma Patients
by: Justin Tong, et al.
Published: (2022-10-01) -
No Impact of NRAS Mutation on Features of Primary and Metastatic Melanoma or on Outcomes of Checkpoint Inhibitor Immunotherapy: An Italian Melanoma Intergroup (IMI) Study
by: Michele Guida, et al.
Published: (2021-01-01) -
Biological Factors behind Melanoma Response to Immune Checkpoint Inhibitors
by: Magdalena Olbryt, et al.
Published: (2020-06-01) -
Modern Aspects of Immunotherapy with Checkpoint Inhibitors in Melanoma
by: Vera Petrova, et al.
Published: (2020-03-01)